Pritam S Jain¹*, Snehal R Dhulgunde² and Mayur P Nandre²

¹Associate Professor, R. C. Patel Institute of Pharmaceutical Education and Research, India
²M. Pharm. Student, R. C. Patel Institute of Pharmaceutical Education and Research, India

*Corresponding Author: Pritam S Jain, Associate Professor, R. C. Patel Institute of Pharmaceutical Education and Research, India.

Received: July 14, 2023; Published: September 07, 2023

Abstract

To identify the quantitative determination of pimecrolimus, a novel, straightforward, and rapid high-performance thin-layer chromatographic method with a derivatization process was created and validated. On a silica gel 60 F254 TLC plate, pimecrolimus was chromatographed using toluene-acetonitrile-glacial acetic acid (6:4:0.5, by volume) as the mobile phase. Pimecrolimus was measured using densitometric analysis in the reflectance mode at 690 nm after being visualised with a derivatization reagent that contained anisaldehyde-sulfuric acid in absolute alcohol. It was discovered that the technique produced compact spots for the drug (Rf= 0.55gb ± 0.03). In the concentration range of 800-4800 ng/spot, the results from the calibration plots' linear regression analysis demonstrated a strong linear relationship with r²=0.9989. According to the International Conference on Harmonization's guidelines, the method's precision, recovery, repeatability, and robustness were all verified. The limit of quantitation was found to be 97.04 ng, while the lowest detectable amount was found to be 28.90 ng. The technique is precise, accurate, reproducible, and selective for the analysis of pimecrolimus, according to statistical analysis of the data. The technique worked well for quantifying and estimating the equilibrium solubility of pimecrolimus both as a bulk drug and in commercially available cream formulations.

 Keywords: Pimecrolimus; HPTLC; Validation; Quantitative Determination

References

1. https://www.accessdata.fda.gov/drugsatfda_docs
2. Lade S and Prasad R. “A New validated stability indicating RP-HPLC Method for Estimation of Pimecrolimus in bulk and Topical Formulations”. International Journal of Advances in Pharmacy and Biotechnology (2015): 33-34.
3. Zheng M., et al. “Simultaneous Determination of Six Immunosuppressants in Human Whole Blood by HPLC-MS/MS Using a Modified QuEChERS Method”. Molecules13 (2022): 4087.
4. Woo I., et al. “Development and validation of a simultaneous analytical method for non‐steroidal therapeutic compounds in cosmetics using liquid chromatography–tandem mass spectrometry”. Journal of Separation Science12 (2021): 2371-2381.
5. Spergel J and Leung D. "Safety of topical calcineurin inhibitors in atopic dermatitis: evaluation of the evidence". Current Allergy and Asthma Reports 4 (2006): 270-274.
6. Eichenfield LF and Beck L. “Elidel (pimecrolimus) cream 1%: a nonsteroidal topical agent for the treatment of atopic dermatitis”. The Journal of Allergy and Clinical Immunology 111 (2003): 1153-1168.
7. Amardeep A and Agarwal S. “Validated spectrophotometric method for determination of tacrolimus in marketed formulation”. IOSR Journal of Pharmacy 2 (2012): 317-321.
8. ICH-Guidelines Q2 (R1), Validation of Analytical Procedures: Text and Methodology (2005).

Citation

Citation: Pritam S Jain., et al. “Development and Validation of HPTLC Method for Estimation of Pimecrolimus in Formulations". Acta Scientific Pharmaceutical Sciences 7.10 (2023): 12-18.

Copyright

Copyright: © 2023 Pritam S Jain., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.